Author: Ken Dropiewski

The global cardiac resynchronization therapy (CRT) market is expected to reach USD 9.2 billion by 2025

LONDON, March 28, 2018 /PRNewswire/ — Download the full report: The global cardiac resynchronization therapy (CRT) market is expected to reach USD 9.2 billion by 2025, according to a new report by Grand View Research, Inc. Increasing prevalence of cardiac disorders and rising incidences of heart failure are expected to boost the CRT market […]

Vascular Insights® Announces New Chief Financial Officer

QUINCY, Mass., March 28, 2018 /PRNewswire/ — Vascular Insights® announced that Lisa Gruttadauria has been appointed Chief Financial Officer. In her most recent positions with Vascular Insights® as Controller and Director of Finance, Lisa has been consistently judicious in her management of the Company’s assets, and an ally in the execution of the Company’s strategic initiatives. She […]

Boston Scientific Prevails In U.K. Edwards Lifesciences Litigation

MARLBOROUGH, Mass., March 28, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced the U.K. Court of Appeal dismissed Edwards Lifesciences‘ appeal and upheld a prior court decision that Edwards’ Sapien 3™ device infringes Boston Scientific patent EP (UK) 2 926 766 and that all claims of that patent are valid. “We […]

2018 Global Electrocardiograph (ECG) Market Report – Projected to Reach $7 Billion in 2022 from $5 Billion in 2016 –

DUBLIN–(BUSINESS WIRE)– The “Global Electrocardiograph (ECG) Market Analysis (2017-2023)” report has been added to’s offering. Electrocardiograph (ECG) Market was valued at $5 billion in 2016, and is estimated to reach $7 billion by 2023, growing at a CAGR of 5.8% during the forecast period. Technological advancements of ECG devices such as their portability, […]

Intact Vascular Welcomes TOBA BTK Trial One-Year Clinical Study Results Publication in Catheterization and Cardiovascular Intervention

WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today welcomed the publication of the Tack Optimized Balloon Angioplasty Below the Knee (TOBA BTK) clinical trial results in the current issue of Catheterization and Cardiovascular Intervention. This multi-center pilot study focused on collecting data supporting the safety and performance of the […]

Inflammation Testing Prompts Care Changes Leading to Significantly Lower Levels in Patients with Increased Cardiovascular Risk Due to Diabetes or Pre-Diabetes

BOCA RATON, Fla., March 27, 2018 /PRNewswire/ — New research from MDVIP and Cleveland HeartLab finds that patients with diabetes, pre-diabetes or no evidence of diabetes whose physicians ordered myeloperoxidase (MPO) inflammation testing achieved sharp reductions in MPO levels over five years. The investigators theorize the levels declined over time as a result […]

Renova Therapeutics Announces Issuance of Patent Covering Delivery and Expression of Paracrine Genes

SAN DIEGO, March 27, 2018 /PRNewswire/ — Renova™ Therapeutics, a biotechnology company developing gene and peptide-based treatments for cardiovascular and metabolic diseases, announced today that the European Patent Office has issued Patent No. 2814513, “Systemic Delivery and Regulated Expression of Paracrine Genes for Cardiovascular Diseases and Other Conditions” to The Regents of the […]

Boston Scientific Announces Conference Call Discussing First Quarter 2018 Financial Results

MARLBOROUGH, Mass., March 26, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2018 on Wednesday, April 25, 2018 at 8:00 a.m. EDT. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and […]

VentureMed Group’s FLEX Scoring Catheter® was Featured in a Successful Live Case at ISET 2018

TOLEDO, Ohio, March 26, 2018 /PRNewswire/ — The FLEX Catheter by VentureMed Group, an innovator in vessel prep, was featured in a live case transmission at the International Symposium of Endovascular Therapy (ISET), in Hollywood, FL. ISET focuses on the advancement of endovascular education, promoting discussions, and providing opportunities to explore new technologies and innovative […]

Pythagoras Medical Receives CE-Mark for the ConfidenHT™ System

HERTSLIYA, Israel, March 26, 2018 /PRNewswire/ –Pythagoras Medical, a cutting edge medical device company established by Rainbow Medical, Israel’s premier medical device investment group, announced today that its ConfidenHT(TM) System has received a European CE Mark. ConfidenHT(TM) is a novel system for patients with resistant hypertension, which improves the efficacy […]